» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Article
VOL. 40 | NO. 31 | Friday, July 29, 2016

GSK, Google parent company to make bioelectronic medicine

Print | Front Page | Email this story

LONDON (AP) — Pharmaceutical giant GlaxoSmithKline is forming a joint venture with a unit of Google's parent that will invest 540 million pounds ($714 million) in the relatively new field of bioelectronic medicine.

GSK and Verily Life Sciences, a subsidiary of Alphabet, have agreed to create a new company known as Galvani Bioelectronics, which will be based in Britain. GSK said Monday that it will own 55 percent of the venture, with Verily owning the rest.

Bioelectronics seeks to treat chronic illnesses using tiny implants to change electronic signals that pass along nerves in the body.

The announcement comes less than a week after GSK pledged to invest 275 million pounds in three plants in Britain, sweeping aside concerns about growth following the country's decision to leave the European Union.

Follow us on Facebook, Twitter & RSS:
Sign-Up For Our FREE email edition
Get the news first with our free weekly email
Name
Email  
TNLedger.com Knoxville Editon
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 0 0 0
MORTGAGES 0 0 0
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 0 0 0
BANKRUPTCIES 0 0 0
BUSINESS LICENSES 0 0 0
UTILITY CONNECTIONS 0 0 0
MARRIAGE LICENSES 0 0 0